EXAS vs ORA · rev $2.76B vs P/E 61, $7.75B cap
EXACT Sciences Corporation (EXAS) versus Ormat Technologies Inc (ORA) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Ormat Technologies Inc (ORA) is a utilities - renewable company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ORA does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. ORA currently screens at market cap $7.75B and trailing P/E 60.6.
Not investment advice. Open the EXAS and ORA stock pages for the full models.
Not investment advice.